A. Markatos

1.5k total citations · 1 hit paper
8 papers, 1.2k citations indexed

About

A. Markatos is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, A. Markatos has authored 8 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 5 papers in Orthopedics and Sports Medicine and 4 papers in Molecular Biology. Recurrent topics in A. Markatos's work include Bone health and treatments (5 papers), Bone health and osteoporosis research (5 papers) and Bone Metabolism and Diseases (4 papers). A. Markatos is often cited by papers focused on Bone health and treatments (5 papers), Bone health and osteoporosis research (5 papers) and Bone Metabolism and Diseases (4 papers). A. Markatos collaborates with scholars based in United States and Italy. A. Markatos's co-authors include Gideon A. Rodan, Marcela Yamamoto, Elena Fattori, Valeria Poli, Gennaro Ciliberto, R. Balena, J.G. Seedor, Brian C. Toolan, M. Shea and Elizabeth Myers and has published in prestigious journals such as Journal of Clinical Investigation, The EMBO Journal and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

A. Markatos

8 papers receiving 1.1k citations

Hit Papers

Interleukin-6 deficient mice are protected from bone loss... 1994 2026 2004 2015 1994 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Markatos United States 7 637 554 501 177 150 8 1.2k
Rana Samadfam Canada 16 459 0.7× 633 1.1× 424 0.8× 42 0.2× 186 1.2× 35 1.0k
Ian Pyrah United States 17 366 0.6× 465 0.8× 356 0.7× 65 0.4× 116 0.8× 32 847
Marilyn Gordon Canada 13 158 0.2× 265 0.5× 147 0.3× 46 0.3× 75 0.5× 17 564
Dorthe Hartwell Denmark 16 108 0.2× 144 0.3× 188 0.4× 134 0.8× 98 0.7× 29 1.0k
Heather Fawcett United States 17 142 0.2× 847 1.5× 125 0.2× 33 0.2× 219 1.5× 41 1.3k
Naohiko Hayakawa Japan 12 153 0.2× 221 0.4× 83 0.2× 113 0.6× 42 0.3× 20 594
M Cammisa Italy 21 83 0.1× 351 0.6× 335 0.7× 20 0.1× 158 1.1× 54 1.1k
Carmen García‐Ibarbia Spain 12 109 0.2× 331 0.6× 113 0.2× 35 0.2× 120 0.8× 30 664
Kazuko Shiozawa Japan 23 277 0.4× 351 0.6× 59 0.1× 410 2.3× 139 0.9× 59 1.4k
K Chihara Japan 17 108 0.2× 188 0.3× 69 0.1× 49 0.3× 75 0.5× 37 568

Countries citing papers authored by A. Markatos

Since Specialization
Citations

This map shows the geographic impact of A. Markatos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Markatos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Markatos more than expected).

Fields of papers citing papers by A. Markatos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Markatos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Markatos. The network helps show where A. Markatos may publish in the future.

Co-authorship network of co-authors of A. Markatos

This figure shows the co-authorship network connecting the top 25 collaborators of A. Markatos. A scholar is included among the top collaborators of A. Markatos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Markatos. A. Markatos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Sureshkumar, Kalathil K., B. M. Patel, A. Markatos, Dai D. Nghiem, & Richard J. Marcus. (2005). Quality of life after organ transplantation in type 1 diabetics with end‐stage renal disease. Clinical Transplantation. 20(1). 19–25. 70 indexed citations
2.
Balena, R., A. Markatos, J.G. Seedor, et al.. (1996). Long-term safety of the aminobisphosphonate alendronate in adult dogs. II. Histomorphometric analysis of the L5 vertebrae.. Journal of Pharmacology and Experimental Therapeutics. 276(1). 277–283. 33 indexed citations
3.
Poli, Valeria, Elena Fattori, A. Markatos, et al.. (1994). Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion.. The EMBO Journal. 13(5). 1189–1196. 617 indexed citations breakdown →
4.
Yamamoto, Michiko, A. Markatos, J.G. Seedor, et al.. (1993). The effects of the aminobisphosphonate alendronate on thyroid hormone-induced osteopenia in rats. Calcified Tissue International. 53(4). 278–282. 26 indexed citations
5.
Balena, R., A. Markatos, Michael A. Gentile, et al.. (1993). The aminobisphosphonate alendronate inhibits bone loss induced by thyroid hormone in the rat comparison between effects on tibiae and vertebrae. Bone. 14(3). 499–504. 22 indexed citations
6.
Balena, R., Brian C. Toolan, M. Shea, et al.. (1993). The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates.. Journal of Clinical Investigation. 92(6). 2577–2586. 316 indexed citations
7.
Balena, R., M. Shea, J.G. Seedor, et al.. (1993). Effects of combined prostaglandin and alendronate treatment on the histomorphometry and biomechanical properties of bone in ovariectomized rats. Journal of Bone and Mineral Research. 8(7). 871–879. 73 indexed citations
8.
Yamamoto, Manabu, et al.. (1992). In vivo effects of thyroid hormones on bone metabolism in adult mice. Bone. 13(5). A39–A39. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026